Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Heart ; 95(9): 715-20, 2009 May.
Artigo em Inglês | MEDLINE | ID: mdl-19036758

RESUMO

AIMS: A nested case-control study of 75 patients with cardiac device infections (CDI) and 75 matched controls was conducted to evaluate time course, risk factors, culture results and frequency of CDI. METHODS AND RESULTS: CDI occurred in 75/3410 (2.2%) device implantation and revision procedures, performed between 2000 and 2007. The time delay between device procedure and infection ranged from 0 to 64 months (mean 14 (SD 16)), 21 patients (28%) had an early infection (<1 month), 26 (35%) a late infection (1-12 months) and 28 (37%) a delayed infection (>12 months). Of interest, 18 (24%) patients presented with an infection >24 months after the device-related procedure. Time delay until infection was significantly shorter when cultures were positive for micro-organisms compared to negative cultures (8 (12) vs 18 (18) months, p = 0.03). Pocket cultures in delayed infections remained more often negative (61% vs 23%, p = 0.01). Independent CDI risk factors were: device revision (odds ratio (OR) 3.67; 95% confidence interval (CI), 1.51 to 8.96), renal dysfunction defined as glomerular filtration rate <60 ml/min (OR 4.64; CI, 1.48 to 14.62) and oral anticoagulation use (OR 2.83; CI 1.20 to 6.68). CONCLUSION: CDI occurred in 2.2% of device procedures, with 24% occurring more than two years after the device-related procedure. Renal dysfunction, device revisions and oral anticoagulation are potent risk factors for CDI.


Assuntos
Desfibriladores Implantáveis/efeitos adversos , Infecções Relacionadas à Prótese/etiologia , Infecções Estafilocócicas/complicações , Idoso , Estudos de Casos e Controles , Infecção Hospitalar/prevenção & controle , Desfibriladores Implantáveis/microbiologia , Remoção de Dispositivo , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Razão de Chances , Infecções Relacionadas à Prótese/diagnóstico , Infecções Relacionadas à Prótese/epidemiologia , Insuficiência Renal/complicações , Medição de Risco , Infecções Estafilocócicas/diagnóstico , Infecções Estafilocócicas/mortalidade , Fatores de Tempo , Resultado do Tratamento
3.
Ned Tijdschr Geneeskd ; 144(43): 2057-61, 2000 Oct 21.
Artigo em Holandês | MEDLINE | ID: mdl-11072509

RESUMO

OBJECTIVE: Evaluation of the results of balloon dilatation in coarctation of the aorta in children. DESIGN: Retrospective. METHOD: In the years 1990-1999 30 patients with a congenital coarctation of the aorta were treated with balloon angioplasty in the Children's Heart Centre of Utrecht University Medical Centre, the Netherlands. The group comprised 5 girls and 25 boys, with a mean age of 4.8 years (range 1 month-16 years) without severe associated congenital heart defects or a long segment coarctation. Follow-up included Doppler echocardiography and MRI within the first 6 years after the procedure. The fall of the pressure gradient was assessed with Student's t-test for paired observations and the reintervention period was calculated by the Kaplan-Meier method. RESULTS: No children died. Of 30 procedures performed, 28 (93%) were considered successful. Mean pressure gradient was reduced from 36.2 mmHg (SD: 12.7) to 13.1 mmHg (SD: 9.3) (p < 0.001). Mean follow-up was 4.1 years; the follow-up of 11 patients was longer than 5 years. Four patients (13%) developed a recoarctation. No aneurysm formation was encountered (n = 14). CONCLUSION: Balloon angioplasty for the treatment of native coarctation of the aorta in children may be an efficient and not very damaging solution for this selected group of patients.


Assuntos
Angioplastia com Balão , Coartação Aórtica/terapia , Adolescente , Fatores Etários , Angioplastia com Balão/efeitos adversos , Criança , Pré-Escolar , Intervalo Livre de Doença , Feminino , Seguimentos , Hospitais Pediátricos , Hospitais Universitários , Humanos , Lactente , Recém-Nascido , Masculino , Países Baixos , Recidiva , Estudos Retrospectivos , Análise de Sobrevida , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...